5-Amino-1MQ 10mg

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase, an enzyme abbreviated to NNMT. It is studied for how blocking that enzyme affects nicotinamide availability and NAD+ salvage within cells. PhaseOne supplies 5 amino 1MQ 10mg as a lyophilised research powder.

No. Despite being listed as "5 amino 1MQ peptide" almost everywhere online, it is not a peptide — it contains no amino acids and no peptide bonds. It is a quinolinium small molecule. The label sticks because it is sold through the same suppliers and researched alongside genuine peptides, but the distinction matters: it behaves differently in solution and in storage. The same confusion surrounds NAD+, which is a coenzyme rather than a peptide.

That colour is expected and is not a sign of contamination. Unlike the white lyophilised powders most research peptides come as, 5-Amino-1MQ is intrinsically yellow to orange, and reconstituted solutions take on a distinctly yellow-orange tint. The quinolinium ring structure absorbs light in the visible range, which is what produces the colour. Researchers new to the compound often assume the vial is wrong or spoiled — it is not. Check the batch COA if you want confirmation of identity and purity.

5-Amino-1MQ appears in listings both as lyophilised powder in vials and as capsules, typically at higher strengths. They are not equivalent products for research purposes — capsule formulations include excipients and carry no batch purity verification. PhaseOne supplies the lyophilised 10mg vial form with a Certificate of Analysis.

PhaseOne ships 5-Amino-1MQ Australia-wide for research use, dispatched locally with tracking, in 10mg vials. Every vial carries a batch-specific Certificate of Analysis verifying ≥99% HPLC purity, so Australian researchers are not relying on overseas listings or unverified stock.

Yes — PhaseOne has 5 amino 1MQ for sale online in 10mg vials, shipped Australia-wide. It appears under several spellings, including 5-amino-1MQ, 5 amino 1MQ and 5amino1MQ, which all refer to the same compound. PhaseOne supplies it as a lyophilised research powder with a batch Certificate of Analysis.

PhaseOne prices 5-Amino-1MQ at A$67.99 for a 10mg vial, reduced from A$84.99, with the batch Certificate of Analysis included at no extra cost. Current pricing is shown on this page.

No. 5-Amino-1MQ is not registered on the ARTG and is not approved for supply as a medicine in Australia, so Chemist Warehouse and other Australian chemists do not stock it in any form. It is supplied as a research compound through research suppliers instead.

Nicotinamide N-methyltransferase methylates nicotinamide, diverting it away from the NAD+ salvage pathway. Published research on 5-Amino-1MQ has examined what happens to cellular nicotinamide and NAD+ handling when that enzyme is inhibited, along with NNMT expression in adipose and metabolic tissue. It is a comparatively young area of research relative to the established peptides.

5-Amino-1MQ is supplied as a lyophilised powder for improved stability during storage and shipping across Australia. Unreconstituted vials should be kept refrigerated and protected from direct light, and are commonly reconstituted using bacteriostatic water prior to research preparation. Expect a yellow-orange solution rather than a clear one. (!) Read our reconstitution guide or bacteriostatic water guide.

As interest in research compounds grows across Australia, transparency and third-party testing have become increasingly important to Australian buyers. All PhaseOne research products are supported by third-party HPLC testing, verified COA reporting, research-grade manufacturing standards, and Australia-wide access. (!) View our COA library.

HPLC testing refers to High Performance Liquid Chromatography, an analytical method used to verify purity and compound identity - a standard PhaseOne applies to every research product sold in Australia.